Phase I trial of the tolerability and pharmacokinetics of BMS 247615 in patients with advanced solid tumours.
Latest Information Update: 23 Dec 2010
Price :
$35 *
At a glance
- Drugs BMS 247615 (Primary)
- Indications Colorectal cancer; Head and neck cancer; Lung cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics